Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Change in Cash (2010 - 2026)

Insmed (INSM) posted Change in Cash of -$37.4 million for Q2 2026, down 152.16% on a QoQ basis from $71.7 million in Q1 2026, and down 104.25% year-over-year from $881.1 million in Q2 2025.

Analysis

Insmed (INSM) Change in Cash (2010 - 2026) Analysis & Trends

Insmed has reported Change in Cash for 17 years, with the latest figure at -$37.4 million in Q2 2026.

  • On a quarterly basis, Change in Cash fell 104.25% year-over-year to -$37.4 million in Q2 2026; TTM through Jun 2026 was -$739.6 million, a 2070.84% decrease from a year earlier, with the FY2025 full-year figure at -$44.6 million, down 161.36% from the prior year.
  • Change in Cash was -$37.4 million for Q2 2026 at Insmed, down from $71.7 million in the prior quarter.
  • The five-year high for Change in Cash was $881.1 million in Q2 2025, with the low at -$949.6 million in Q3 2025.
  • Average Change in Cash over 5 years is -$9.6 million, with a median of -$21.1 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash slumped 8603.74% in 2023, then jumped 2074.66% in 2024.
  • Over 5 years, Change in Cash stood at $659.4 million in 2022, then tumbled by 100.72% to -$4.7 million in 2023, then surged by 2074.66% to $93.6 million in 2024, then jumped by 87.74% to $175.7 million in 2025, then plunged by 121.3% to -$37.4 million in 2026.
  • The last three Change in Cash figures came in at -$37.4 million (Q2 2026), $71.7 million (Q1 2026), and $175.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -4.45 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 649.20 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -504.60 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -185.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -2.94 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -2.09 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -37.42 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -230.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.42 Mn
Mar 31, 2026 71.74 Mn
Dec 31, 2025 175.68 Mn
Sep 30, 2025 -949.56 Mn
Jun 30, 2025 881.08 Mn
Mar 31, 2025 -151.78 Mn
Dec 31, 2024 93.58 Mn
Sep 30, 2024 -785.35 Mn
Jun 30, 2024 651.07 Mn
Mar 31, 2024 113.36 Mn
Dec 31, 2023 -4.74 Mn
Sep 30, 2023 -125.77 Mn
Jun 30, 2023 -356.03 Mn
Mar 31, 2023 -105.13 Mn
Dec 31, 2022 659.40 Mn
Sep 30, 2022 -1.45 Mn
Jun 30, 2022 -99.63 Mn
Mar 31, 2022 -201.08 Mn
Dec 31, 2021 -129.77 Mn
Sep 30, 2021 -81.77 Mn